Search
for

    Sort by

    Research 331–360 of 1000+

    1. Risk of Depression after 5 Alpha Reductase Inhibitor Medication: Meta-Analysis The World Journal of Men's Health · 2019 · 4 citations
    2. ORAL AND TOPICAL FINASTERIDE IN THE TREATMENT OF MALE ANDROGENETIC ALOPECIA – NARRATIVE REVIEW Archiv Euromedica · 2026
    3. Pharmacological Role and Clinical Applications of 5α-Reductase Inhibitors-Review Article for Pharmacists and Healthcare Professionals 2025
    4. HPLC Profiling and Insilco studies of Chochurus olitoris (Jute) Leave Fractions against Steroid 5α-Reductase 2 (SRD5α2) Biomedical Journal of Scientific & Technical Research · 2024
    5. 410 NON-INVASIVE DIAGNOSIS OF PROSTATE CANCER FROM BODY FLUIDS USING A PANEL OF TUMOR SUPPRESSOR GENES European Urology Supplements · 2011
    6. Patent Evaluation: Δ-4,6-Steroids as Potent 5α-Reductase Inhibitors Current opinion in therapeutic patents · 1992
    7. Is there a relationship between androgenic alopecia and benign prostatic hyperplasia? DOAJ (DOAJ: Directory of Open Access Journals) · 2015 · 3 citations
    8. Clinical use of 5α-reductase inhibitors Cambridge University Press eBooks · 2001 · 3 citations
    9. 5α-Reductase Inhibitory Potential of <i>Hibiscus rosa sinensis</i>: Effective for the Management of Alopecia Journal of Natural Remedies · 2023
    10. 천연식물을 이용한 AT-Grow의 발모효과 한국화장품미용학회지 · 2015
    11. A Review on Finasteride: A 5-Alpha Reductase Inhibitors, its Mechanism, Facts and Benefits Journal of Drug Delivery and Therapeutics · 2019
    12. Association between Androgenic Hair Patterns and Prostate Cancer Risk in South Indian Men: A Case-control Study from the Cauvery Delta. PubMed · 2026
    13. Finasteride: Middle-Age Cure-All for Alopecia and Benign Prostatic Hyperplasia? Mayo Clinic Proceedings · 2006
    14. Nutritional Pharmacology and Mechanistic Insights of Saw Palmetto in Male Endocrine and Prostatic Disorders Zenodo (CERN European Organization for Nuclear Research) · 2025
    15. A comment on the post-finasteride syndrome International Journal of Trichology · 2018 · 11 citations
    16. Dutasteride Drugs · 2008 · 45 citations
    17. Finasteride and Male Breast Cancer: Does the MHRA Report Show a Link? PubMed · 2010 · 12 citations
    18. Assessing dutasteride-associated sexual dysfunction using the U.S. Food and Drug Administration Adverse Event Reporting System Journal of the European Academy of Dermatology and Venereology · 2017 · 7 citations
    19. Dihydrotestosterone and 5α-Reductase Humana Press eBooks · 2003
    20. El perquè del Palau Catalunya música: Revista musical catalana · 2008
    21. Inhibitors of 5α -Reductase Type I in LNCaP Cells from the Roots of Angelica koreana Planta Medica · 2002 · 22 citations
    22. The Post-finasteride Syndrome: Clinical Manifestation of Drug-Induced Epigenetics Due to Endocrine Disruption Current Sexual Health Reports · 2018 · 8 citations
    23. Synthesis of Spiro[cyclohexane-1,2?-[2H]indene] derivatives as inhibitors of steroid 5?-reductase Helvetica Chimica Acta · 1995 · 8 citations
    24. HPLC characterization, molecular docking, QSAR and molecular dynamics simulation of Alstonia boonei phytochemical analogs as potent 5-alpha reductase inhibitors Discover Chemistry. · 2025 · 2 citations
    25. Clinical Pearls in Men's Health Mayo Clinic Proceedings · 2010 · 1 citations
    26. Finasteride. dutasteride risk of suicide and sexual dysfunction Reactions Weekly · 2026
    27. FINASTERIDE IN MODERN MEDICINE: THERAPEUTIC APPLICATIONS AND SYSTEMIC HEALTH IMPLICATIONS RS Global journals (RS Global Sp. z O.O.) · 2026
    28. Possible Role of Osteopathic Manipulation Treatment in Alleviation of Finasteride-Induced Dementia through Modulation of HOMER-3 Gene Methylation Physiology · 2025
    29. Glatze in jungen Jahren könnte Risikofaktor für BPH sein Uro-News · 2012
    30. 5α-Reductase inhibitor therapy: Should physicians be concerned with persistent diminished libido, erectile dysfunction and depression in a subset of patients? Journal of Men's Health · 2010